0001235802-19-000134.txt : 20191120
0001235802-19-000134.hdr.sgml : 20191120
20191120165206
ACCESSION NUMBER: 0001235802-19-000134
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191118
FILED AS OF DATE: 20191120
DATE AS OF CHANGE: 20191120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dewey Julie D.
CENTRAL INDEX KEY: 0001218011
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35065
FILM NUMBER: 191234839
MAIL ADDRESS:
STREET 1: 1023 CHERRY ROAD
CITY: MEMPHIS
STATE: TN
ZIP: 38117
FORMER NAME:
FORMER CONFORMED NAME: TRACY JULIE D
DATE OF NAME CHANGE: 20041008
FORMER NAME:
FORMER CONFORMED NAME: TRACEY JULIE D
DATE OF NAME CHANGE: 20030210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Wright Medical Group N.V.
CENTRAL INDEX KEY: 0001492658
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 980509600
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1229
BUSINESS ADDRESS:
STREET 1: PRINS BERNHARDPLEIN 200
CITY: AMSTERDAM
STATE: P7
ZIP: 1097JB
BUSINESS PHONE: 901-867-4317
MAIL ADDRESS:
STREET 1: 1023 CHERRY ROAD
CITY: MEMPHIS
STATE: TN
ZIP: 38117
FORMER COMPANY:
FORMER CONFORMED NAME: Tornier N.V.
DATE OF NAME CHANGE: 20110201
FORMER COMPANY:
FORMER CONFORMED NAME: Tornier B.V.
DATE OF NAME CHANGE: 20100524
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-11-18
0
0001492658
Wright Medical Group N.V.
WMGI
0001218011
Dewey Julie D.
1023 CHERRY ROAD
MEMPHIS
TN
38117
0
1
0
0
SVP, Chief Comm. Officer
Ordinary Shares, par value EUR 0.03 per share
2019-11-18
4
M
0
16341
17.79
A
42899
D
Ordinary Shares, par value EUR 0.03 per share
2019-11-18
4
M
0
987
17.7
A
43886
D
Ordinary Shares, par value EUR 0.03 per share
2019-11-18
4
M
0
7324
20.75
A
51210
D
Ordinary Shares, par value EUR 0.03 per share
2019-11-18
4
M
0
1776
22.55
A
52986
D
Ordinary Shares, par value EUR 0.03 per share
2019-11-18
4
M
0
8232
23.93
A
61218
D
Ordinary Shares, par value EUR 0.03 per share
2019-11-18
4
M
0
54437
20.62
A
115655
D
Ordinary Shares, par value EUR 0.03 per share
2019-11-18
4
M
0
19997
21.24
A
135652
D
Ordinary Shares, par value EUR 0.03 per share
2019-11-18
4
M
0
6983
27.86
A
142635
D
Ordinary Shares, par value EUR 0.03 per share
2019-11-18
4
M
0
3892
24.49
A
146527
D
Ordinary Shares, par value EUR 0.03 per share
2019-11-18
4
S
0
119969
29.4938
D
26558
D
Stock Option (right to buy)
17.79
2019-11-18
4
M
0
16341
0
D
2021-10-17
Ordinary Shares
16341
0
D
Stock Option (right to buy)
17.7
2019-11-18
4
M
0
987
0
D
2022-04-16
Ordinary Shares
987
0
D
Stock Option (right to buy)
20.75
2019-11-18
4
M
0
7324
0
D
2022-05-09
Ordinary Shares
7324
0
D
Stock Option (right to buy)
22.55
2019-11-18
4
M
0
1776
0
D
2023-04-17
Ordinary Shares
1776
0
D
Stock Option (right to buy)
23.93
2019-11-18
4
M
0
8232
0
D
2023-05-14
Ordinary Shares
8232
0
D
Stock Option (right to buy)
20.62
2019-11-18
4
M
0
54437
0
D
2025-10-13
Ordinary Shares
54437
0
D
Stock Option (right to buy)
21.24
2019-11-18
4
M
0
19997
0
D
2026-07-19
Ordinary Shares
19997
4642
D
Stock Option (right to buy)
27.86
2019-11-18
4
M
0
6983
0
D
2027-07-25
Ordinary Shares
6983
5443
D
Stock Option (right to buy)
24.49
2019-11-18
4
M
0
3892
0
D
2028-07-24
Ordinary Shares
3892
8568
D
Exercise and sale of vested stock options in connection with 280G tax planning.
Includes 2,144 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 5,588 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 4,616 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.48 to $29.51, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
This option has fully vested.
This option vested with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
This option vested with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
This option vested with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
/s/ Marija Nelson, attorney-in-fact
2019-11-20